BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 16 filers reported holding BIOANALYTICAL SYS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $830,000 | +157.0% | 67,510 | 0.0% | 0.02% | +157.1% |
| Q3 2020 | $323,000 | -5.8% | 67,510 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $343,000 | +55.9% | 67,510 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $220,000 | -50.2% | 67,510 | -24.3% | 0.01% | -16.7% |
| Q4 2019 | $442,000 | +1.6% | 89,210 | -26.3% | 0.01% | 0.0% |
| Q3 2019 | $435,000 | +82.0% | 121,110 | 0.0% | 0.01% | +100.0% |
| Q2 2019 | $239,000 | -4.8% | 121,110 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $251,000 | +63.0% | 121,110 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $154,000 | -29.4% | 121,110 | -10.4% | 0.00% | 0.0% |
| Q3 2018 | $218,000 | -2.2% | 135,110 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $223,000 | +3.2% | 135,110 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $216,000 | -51.0% | 135,110 | -24.3% | 0.00% | -60.0% |
| Q4 2017 | $441,000 | +558.2% | 178,510 | +362.3% | 0.01% | +400.0% |
| Q3 2017 | $67,000 | +59.5% | 38,610 | +56.9% | 0.00% | 0.0% |
| Q2 2017 | $42,000 | – | 24,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 320,234 | $650,000 | 0.45% |
| Kessler Investment Group, LLC | 42,841 | $87,000 | 0.15% |
| NORTH STAR ASSET MANAGEMENT INC | 20,000 | $41,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 3 | $0 | 0.00% |
| UBS Group AG | 5,118 | $10,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 54,038 | $110,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 100 | $203,000 | 0.00% |
| STATE STREET CORP | 10,200 | $20,000 | 0.00% |
| MORGAN STANLEY | 14 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 230 | $0 | 0.00% |